v3.26.1
Convertible and Redeemable Preferred Stock and Stockholders’ Deficit (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Warrants

  

Type of Warrants  Underlying Common
Stock to be Purchased
  

Exercise

Price

   Issue Date  Exercise Period 
Common Warrants   8,003   $735.00   January 13, 2022  March 1, 2022 to March 1, 2027 
Common Warrants   8,303   $897.56   March 1, 2022  March 1, 2022 to March 1, 2027 
Common Warrants   6,666   $309.56   May 4, 2022  May 4, 2022 to May 4, 2027 
Common Warrants   894,194   $0.0154   May 24, 2022  May 24, 2022 to May 24, 2027 
Common Warrants   582,886   $0.0154   June 28, 2022  May 24, 2022 to June 28, 2027 
Common Warrants   49,227   $0.0154   December 21, 2022  December 21, 2022 to December 21, 2027 
Common Warrants   130,461   $0.0154   February 17, 2023  February 17, 2023 to February 17, 2028 
Common Warrants   258,584   $0.0154   March 20, 2023  March 20, 2023 to March 20, 2028 
Common Warrants   369,231   $0.0154   April 5, 2023  April 5, 2023 to April 5, 2028 
Common Warrants   349,463   $0.0154   July 3, 2023  July 3, 2023 to July 3, 2028 
Common Warrants   615,384   $0.0154   August 4, 2023  August 4, 2023 to August 4, 2028 
Common Warrants   12,721,893   $0.0154   September 27, 2023  September 27, 2023 to September 27, 2028 
Common Warrants   149,850,150   $0.0154   April 8, 2025  April 8, 2025 to April 8, 2030 
Common Warrants   92,407,592   $0.0154   June 26, 2025  June 26, 2025 to June 26, 2030 
Prefunded Common Warrants   4,807,692   $0.0010   September 27, 2023  September 27, 2023 to September 27, 2028 
Total   263,059,729             
Summary of Common Stock Reserved for Future Issuance

Common Stock reserved for future issuance is as follows in common equivalent shares as of June 30, 2026:

  

Common Stock issuable upon the exercise of stock options outstanding   3,324 
Common Stock issuable upon the exercise of Common Stock warrants   8,220,852 
Common Stock available for future issuance under the 2019 ESPP   509 
Common Stock available for future issuance under the Inducement Plan   609 
Common Stock available for future issuance under the 2025 Plan   55,067,437 
Common Stock reserved for the exercise of purchase rights   1,123,704,985 
Common Stock reserved for the conversion of convertible notes   614,438,817 
Common Stock reserved for the conversion of series E-1 preferred stock   51,158,308 
Common Stock reserved for the conversion of series G-1 preferred stock   103,383,799 
Total Common Stock reserved for future issuance(1)   1,955,978,640 

 

(1) The potentially dilutive securities in Note 2 – Summary of Significant Accounting Policies includes all potentially dilutive securities that are not included in the diluted net income (loss) per share as per U.S. GAAP, whereas the total Common Stock reserved for future issuance in the table above includes the shares that must legally be reserved based on the applicable instruments’ agreements.